Statistical analysis plan for the Diagnosing deep-vein Thrombosis early in critically ill patients (DETECT) trial: a study protocol for a randomized controlled trial

Background Deep vein thrombosis (DVT) in critically ill patients is often undetected and could lead to pulmonary embolism (PE) and subsequent morbidity and mortality. Ultrasound surveillance for DVT may facilitate early detection and treatment of DVTs in high-risk medical-surgical ICU patients and thus may improve patient outcomes. Objective The Diagnosing deep-vein thrombosis early in critically ill patients (DETECT) trial aims to evaluate the effect of twice-weekly surveillance bilateral lower limb ultrasound compared to usual care on 90-day mortality of critically ill adults admitted to medical, surgical, and trauma ICUs. Methods/Design In this multicenter randomized trial, critically ill patients will be randomized to twice-weekly surveillance bilateral lower limb ultrasound (surveillance group) or usual care group. The primary outcome is 90-day mortality. The trial has 80% power to detect a 6% absolute risk reduction in 90-day mortality from 30 to 24%. Secondary outcomes include lower limb proximal DVT, pulmonary embolism and clinically important bleeding. Results As of May 31, 2026 a total of 1721 patients have been recruited from 15 centers across Saudi Arabia and Kuwait. Discussion This statistical analysis plan for the DETECT Trial was developed following international guidelines. This plan specifies a priori the statistical methods for evaluating primary and secondary outcomes and defines covariables for adjusted analyses. Trial registration Clinicaltrials.gov NCT05112705 (registered on 2021-10-26 and posted on 2021-11-09 after quality check).

Authors

Institutions

Publication Details

Journal
F1000Research
Published
2026-11-16
DOI
https://doi.org/10.12688/f1000research.190934.1
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Statistical analysis plan for the Diagnosing deep-vein Thrombosis early in critically ill patients (DETECT) trial: a study protocol for a randomized controlled trial

Abdalmohsen Abdulelah Ababtain, Fahad M. Al-Hameed, Ahmad Al Khalaf, Abdullah Al Tamimi et al.
2 links
F1000Research
Venous Thromboembolism Diagnosis and Management
article

Statistical analysis plan for the Diagnosing deep-vein Thrombosis early in critically ill patients (DETECT) trial: a study protocol for a randomized controlled trial

Abdalmohsen Abdulelah Ababtain, Fahad M. Al-Hameed, Ahmad Al Khalaf, Abdullah Al Tamimi, Waleed A. Alhazzani, Jesna Jose, Ali Mousa Alahmari, Amjad Alhumaidan, Rakan Alqahtani, Sarah Fadel Buabbas, Marwa Ridha Amer, Jamal Chalabi, Felwa Bin Humaid, Abdulrahman Abdullah Al-Fares, Wafa Mansoor Hazem, Ayman Kharaba, Shaya Yaanallah AlQahtani, Gulam Rasool, Musharaf Sadat, Husam Ismail Ardah, Haifaa Ibrahim AlHumedi, Haifa Mesfer Algethamy, G. Almaziad, Yaseen M. Arabi, Farhan Zayed Alenezi, Khalid A. Maghrabi, Abdulaziz Al‐Dawood, Mohammed J Brembali, Mohammed S. Alshahrani, Mohammed Alqahtani, Osama Ahmed Elfaki, Saudi Critical Care Trials Group
article en

Abstract

Background Deep vein thrombosis (DVT) in critically ill patients is often undetected and could lead to pulmonary embolism (PE) and subsequent morbidity and mortality. Ultrasound surveillance for DVT may facilitate early detection and treatment of DVTs in high-risk medical-surgical ICU patients and thus may improve patient outcomes. Objective The Diagnosing deep-vein thrombosis early in critically ill patients (DETECT) trial aims to evaluate the effect of twice-weekly surveillance bilateral lower limb ultrasound compared to usual care on 90-day mortality of critically ill adults admitted to medical, surgical, and trauma ICUs. Methods/Design In this multicenter randomized trial, critically ill patients will be randomized to twice-weekly surveillance bilateral lower limb ultrasound (surveillance group) or usual care group. The primary outcome is 90-day mortality. The trial has 80% power to detect a 6% absolute risk reduction in 90-day mortality from 30 to 24%. Secondary outcomes include lower limb proximal DVT, pulmonary embolism and clinically important bleeding. Results As of May 31, 2026 a total of 1721 patients have been recruited from 15 centers across Saudi Arabia and Kuwait. Discussion This statistical analysis plan for the DETECT Trial was developed following international guidelines. This plan specifies a priori the statistical methods for evaluating primary and secondary outcomes and defines covariables for adjusted analyses. Trial registration Clinicaltrials.gov NCT05112705 (registered on 2021-10-26 and posted on 2021-11-09 after quality check).

F1000ResearchVol. 15
Ministry of Defence (GB), Riyadh Armed Forces Hospital (SA), Alfaisal University (SA), King Abdulaziz University (SA), King Saud bin Abdulaziz University for Health Sciences (SA), King Faisal Specialist Hospital & Research Centre (SA), King Fahd Hospital of the University (SA), King Saud University (SA), Amiri Hospital (KW), King Abdullah International Medical Research Center (SA), Prince Mohammed bin Abdulaziz Hospital (SA), King Abdul Aziz University Hospital (SA), Ministry of Health (KW), Al-Sabah Hospital (KW), King Abdulaziz Hospital (SA), King Fahad Hospital Jeddah (SA), Ministry of Defense (SA), Armed Forces Hospital Southern Region (SA), Research and Innovation Institute (SA), King Abdulaziz Hospital (SA), National Guard Health Affairs (SA), Imam Abdulrahman Bin Faisal University (SA)
Cardiff University, University of Toronto, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon